PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of neuroncolAboutAuthor GuidelinesEditorial BoardNeuro-Oncology
 
Neuro Oncol. 2008 April; 10(2): 232.
PMCID: PMC2613828

Call for Abstracts

Society for Neuro-Oncology 13th Annual Scientific Meeting

Loews Lake Las Vegas Resort Las Vegas, Nevada

Abstracts due: May 15th, 2008

www.soc-neuro-onc.org

Dear Colleagues,

The Society for Neuro-Oncology (SNO) is pleased to announce that the 13th Annual SNO Scientific Meeting will take place at the Loews Las Vegas Resort in Lake Las Vegas, Nevada, on November 20–23, 2008.

The Annual SNO Scientific Meeting continues to attract a growing number of both investigators and practitioners and it is the premier venue at which exciting new ideas and results can be shared, new collaborations can be established, and new friendships can be formed. To continue to make this meeting a valuable experience for all attendees, the SNO Board of Directors and the Conference Planning Committee have worked for over a year, developing an integrated program that promises to be of interest to basic scientists, applied researchers, clinical investigators and full-time practitioners.

The program will feature popular and informative plenary sessions and informal poster sessions, as well as an Education Day, at which attendees can catch up with breaking areas of research and controversies in the field. We have also added a new feature: Select Poster Review sessions. These sessions feature the top-rated posters which will be available for attendee review, and which will also be discussed by an invited speaker. Once again, abstracts for the meeting can be submitted electronically on-line through the SNO website, www.soc-neuro-onc.org. The submission process was successfully implemented for the first time last year and streamlines both the application submission and review processes.

The upcoming meeting in Lake Las Vegas promises to be our biggest and best meeting yet (you can bet on it!), and on behalf of SNO I encourage you to submit your work and join us for what will be an exciting and valuable experience.

Sincerely,

Michael A. Vogelbaum M.D., Ph.D.

Chair, Scientific Program Committee

OVERVIEW

Expect the most comprehensive review of cutting-edge laboratory and clinical research in the field of neuro-oncology at the 13th Annual SNO Scientific Meeting, November 20–23, 2008. The meeting will take place in the resort area of Lake Las Vegas, a short drive from the famed Las Vegas Strip.

An external file that holds a picture, illustration, etc.
Object name is neu10-2-232f1.jpg

The 13th Annual SNO Scientific Meeting is designed for neurosurgeons, neuro-oncologists, medical oncologists, neuropathologists, radiation oncologists, neuroradiologists, pediatricians, laboratory scientists, nurses and other specialists involved in the research, diagnosis, care and treatment of central nervous system tumors.

EDUCATIONAL OBJECTIVES

Abstracts will be chosen on the basis of their research merit and their conformation with the following educational objectives for this meeting. After attending conference sessions, participants should be able to achieve these objectives:

  • Summarize current studies on epidemiologic factors associated with central nervous system tumors
  • Describe the impact of brain tumors and their treatments on patients, quality of life, and neurocognitive intervention strategies
  • Discuss new research on cell biology, signal transduction inhibition strategies, andfactors associated with angiogenesis and invasion in brain tumors
  • Summarize new research on genes that are associated with brain tumors and related therapeutic strategies
  • Discuss new research on CNS antitumor immuno-reactivity
  • Describe advances in imaging and neuropathology as they relate to diagnosis, prognosis, and response to therapy for patients with CNS tumors
  • Discuss advances in pharmacology, experimental therapeutics, and radiobiology that may improve future therapies for patients with CNS tumors
  • Compare results of new clinical studies for central nervous system tumors, and
  • Summarize quality of life or symptom management initiatives beneficial to brain tumor patients.

PRESENTATION CATEGORIES

  • Cell Biology & Signaling
  • Epidemiology
  • Experimental Therapeutics
  • Genomics/Proteomics
  • Immunology
  • In vitro/In vivo Models
  • Medical Oncology
  • Neuro-cognitive studies
  • Pathology/Prognostic Markers
  • Quality of Life/Symptom Management
  • Radiation Oncology
  • Radiology
  • Stem Cells
  • Surgical Oncology

CME INFORMATION

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council of Continuing Medical Education through the joint sponsorship of the University of Texas Medical Branch at Galveston and the Society for Neuro-Oncology. The University of Texas Medical Branch at Galveston is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Medical Branch at Galveston designates this educational activity for a maximum of “To Be Determined” AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Abstract Submission Deadline: May 15, 2008


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press